Cargando…
Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network
Prostate cancer is still a significant global health burden in the coming decade. Novel biomarkers for detection and prognosis are needed to improve the survival of distant and advanced stage prostate cancer patients. The tumor microenvironment is an important driving factor for tumor biological fun...
Autores principales: | Zhang, Tengfei, Wang, Yaxuan, Dong, Yiming, Liu, Lei, Han, Yikai, Wang, Huanrong, Wei, Qian, Xia, Peige, Ma, Wang, Li, Lifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783709/ https://www.ncbi.nlm.nih.gov/pubmed/35075375 http://dx.doi.org/10.1155/2022/1909196 |
Ejemplares similares
-
Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer
por: Xiang, Jun, et al.
Publicado: (2022) -
Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis
por: Sun, Yifan, et al.
Publicado: (2022) -
Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis
por: Yin, Xin, et al.
Publicado: (2020) -
Identification and analysis of survival-associated ceRNA triplets in prostate adenocarcinoma
por: Li, Fan, et al.
Publicado: (2019) -
Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA
por: Su, Rongjia, et al.
Publicado: (2021)